Cannabis-focused group Valens GroWorks Corporation (CSE: VGW) has bolstered its business development - receiving an ISO 17025 accreditation for cannabis testing.
Notably, said Valens, it is the first dealer's license using cannabis as it's matrix in Canada to achieve this accreditation.
The scope of the accreditation includes methods for cannabinoids, pesticides, toxic metals, terpenes and residual solvents.
"I am very proud of our team. It is critical that all cannabis testing labs demonstrate that they can achieve similar performance standards so that consumers can trust that products tested are safe," said Dr Rob O'Brien, Valens' chief scientific officer (CSO) after wholly-owned subsidiary Supra THC Services received the accreditation.
"Transparency is essential in this sector, and we are committed to help lead the way.
"Securing testing results from an ISO 17025 accredited laboratory is the best way for producers to ensure that they are producing high-quality, safe products.
"I would like to see Health Canada mandate that all licensed testing labs demonstrate that they can meet a similar standard."
Last week, Valens unveiled some new names in management, including a new finance chief.
He is Chris Buysen who has more than 15 years' financial experience working as a senior executive with many public and private organisations in a wide range of industries.
He will manage the firm's expected growth in the near term as the company explores opportunities in international financial and retail markets.